Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03801330
Other study ID # HL137502
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2020
Est. completion date April 25, 2023

Study information

Verified date June 2023
Source Blue Marble Rehab Inc
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to measure the feasibility of use of a digital pulmonary rehabilitation tool compared with standard care home program pulmonary rehabilitation.


Description:

The study design is a between subjects (Usual care/App) repeated measures (pre/post) design to compare the feasibility of usual care compared with the digital app, Inspiration Point, used in the home for 8 weeks.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date April 25, 2023
Est. primary completion date April 25, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Participants will have physician permission and diagnosis COPD (FEV1 >30%-80%), - Gold level A-D, and - Ability to perform the 6 Minute Walk Test (6MWT). - This means that participants must meet the standard definition of COPD and have a post-bronchodilator measurement of FEV1/FVC < 0.7. - All COPD Assessment Test scores will be accepted. - Patients must have an mMRC score = 1-4. - Additionally, patients must have taken a Pulmonary Function Test within 1 year or they must retake (for baseline measurement) before participating in the study. - Patients must not have had a Pulmonary Rehabilitation class within the last 6 months. - If participants have had a recent cardiac event within 6 months (such as a myocardial infarction or an abnormal cardiac catheterization) they must obtain cardiologist approval before participating in the study. - In an effort to evaluate feasibility we will request that participants have their own Wi-Fi. Participants may use their own mobile device if they prefer but Blue Marble will have ample supply to provide to participants a device for the purposes of this study. - Target representativeness for gender, based on COPD demography will be ~50% women, based on recent trends indicating that women have an equal, and perhaps slightly greater risk of COPD compared to men3. - The Ethnicity/Race target recruitment, consistent with the US and the population at each site. - Participants must speak, read, and understand English at or above the 6th-grade level (as indicated by having a driver's license or self-report of completion of some high school). Exclusion Criteria for participants with COPD: - Pulmonary functional fitness that precludes participation in outpatient/home PR program (i.e. requires in-patient supervision or severity of a co-morbidity that represents a contradiction to exercise in a self-directed program) will be exclusionary. - A participant who desaturates below SaO2 <88% during the pre-test 6MWT and does not have personal oxygen available will be referred for further evaluation and can be included once they have an O2 titration and supplemental oxygen. - Other exclusions include if a patient's oxygen use exceeds 4 liters per minute (LPM) or those who score less than 100 meters during the entry 6-minute walk distance. - Participants with coronary problems will be excluded based on specific morbidity and severity. These coronary exclusions include coronary artery disease with unstable angina. - Additional exclusions include: any respiratory disorder other than COPD that contraindicates participation in a home-based program. - The inability to learn how to use Inspiration Point - An acute neurological or cardiovascular condition such as stroke or acute heart surgery. - Active cancer with an anticipated survival of less than 6 months or treatment that will preclude them from participating in Pulmonary Rehab. - A participant with high fall risk as per physician determination. - The presence of a neurologic disorder that precludes a potential participant from following a typical COPD exercise program or demonstrating hand function sufficient to interface with the tablet. - This also includes patients with prior or current neurologic event/condition presenting fall risk or requiring assist device for ambulation will also be excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Usual Care Pulmonary Rehabilitation Program
Participants in the Usual Care Pulmonary Rehabilitation Program group will complete an 8 week clinic based Pulmonary Rehabilitation Program (usual care).
Pulmonary Rehabilitation Software-Based Home Program
Participants in the Pulmonary Rehabilitation Software-Based Home Program group will complete an 8-week home-based Pulmonary Rehabilitation Program using a software app (software)

Locations

Country Name City State
United States Wake Forest Baptist Health Charlotte North Carolina
United States Cabin Creek Health Systems Inc Dawes West Virginia
United States Duke University Healthcare Durham North Carolina
United States New River Health Association Scarbro West Virginia

Sponsors (2)

Lead Sponsor Collaborator
Blue Marble Rehab Inc Wake Forest University Health Sciences

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary 6 Minute Walk Test Measures distance walked in 6 minutes Change from baseline 6 Minute Walk Test score at 2 months
Secondary Modified Medical Research Council Dyspnea Scale (mMRC) Single question questionnaire describing shortness of breath. Total Score Range from 0-4, 0 is better. Change from baseline Modified Medical Research Council Dyspnea Scale (mMRC) score at 2 months
Secondary Medical Outcomes Scale VR-12 Survey of health status and quality of life
From (https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/scoring.html) "Scoring the RAND 36-Item Health Survey is a two-step process. First, precoded numeric values are recoded per the scoring key given in Table 1. Note that all items are scored so that a high score defines a more favorable health state. In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores represent the percentage of total possible score achieved. In step 2, items in the same scale are averaged together to create the 8 scale scores. Table 2 lists the items averaged together to create each scale. Items that are left blank (missing data) are not taken into account when calculating the scale scores. Hence, scale scores represent the average for all items in the scale that the respondent answered."
Change from baseline VR-12 score at 2 months
Secondary St Georges Respiratory Questionnaire (SGRQ) A self-administered disease-specific instrument designed to measure the impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease. The questionnaire has 50 items Scores range from 0-100, with higher scores indicating more limitations
https://www.thoracic.org/members/assemblies/assemblies/srn/questionaires/sgrq.php
Change from baseline St Georges Questionnaire score at 2 months
Secondary Lung Information Needs Questionnaire (LINQ) The questionnaire used to identify a person with COPD's need for information about their disease. The questionnaire measures the extent to which the patient needs more information, as perceived by the patient and clinician. It is scored to produce an overall score and 6 domain scores (Disease knowledge, medicines, self-management, exercise, diet, smoking).
The score is the sum of all 6 domains with a range from 0-25. High scores indicate high information needs, a lower score is better.
Change from baseline Lung Information Needs Questionnaire score at 2 months
Secondary Software Usability Scale (SUS) Measures usability and learnability of software tools. Total Score provides percentile score indicating usability/learnability. Range 0-100, Higher (100%) is better. Change from baseline Software Usability Scale (SUS)score at 2 months
Secondary Timed Up and Go Test (TUG) Measures the time taken to stand up from a chair, walk 10 feet, turn around, and return to sitting. Change from baseline TUG score at 2 months
Secondary 30 Second Sit to Stand Test (30STST) Measures the number of times a participant can stand from a seated position in 30 seconds Change from baseline 30STST score at 2 months
Secondary 4 Stage Balance Test (4SBT) Measures balance in 4 increasing more challenging positions Change in 4STBT score at 2 months
Secondary COPD Assessment Test (CAT) An 8 item test which measures the effect of COPD on a patient's overall health. The items on this test measure a patient's cough, sputum, breathlessness, chest tightness, confidence, activity, sleep and energy levels Change in CAT score at 2 months
Secondary Depression Screen (DS) A 2 question survey which can be used to evaluate your risk of depression Change in DS score at 2 months
Secondary Charlson Index (CCI) The Charlson comorbidity index predicts the one-year mortality for a patient who may have a range of comorbid conditions, such as heart disease or cancer (a total of 22 conditions). This index is helpful to ensure the groups are equal for the study comparison and statistics. Change in CCI score at 2 months
Secondary Fall Risk Questionnaire (FRQ) The FRQ is comprised of 13 questions about a person's history of falls and potential fall risk. Change in FRQ score at 2 months
Secondary Positive Affect and Well-Being Short Form (PROMIS) This test is a health-related quality of life questionnaire. Change in PROMIS score at 2 months
Secondary Single Item Literacy Screener (SILS) The SILS is a single item survey which determines literacy and health literacy. It is a direct assessment of a patient's need for assistance in reading health materials. Change in SILS score at 2 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06000696 - Healthy at Home Pilot
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Completed NCT04105075 - COPD in Obese Patients
Recruiting NCT05825261 - Exploring Novel Biomarkers for Emphysema Detection
Active, not recruiting NCT04075331 - Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial Phase 2/Phase 3
Terminated NCT03640260 - Respiratory Regulation With Biofeedback in COPD N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
Withdrawn NCT04210050 - Sleep Ventilation for Patients With Advanced Hypercapnic COPD N/A
Terminated NCT03284203 - Feasibility of At-Home Handheld Spirometry N/A
Recruiting NCT06110403 - Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness Phase 1/Phase 2
Active, not recruiting NCT06040424 - Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Recruiting NCT04868357 - Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program N/A
Completed NCT01892566 - Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV N/A
Completed NCT04119856 - Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD N/A
Completed NCT04485741 - Strados System at Center of Excellence
Completed NCT03626519 - Effects of Menthol on Dyspnoea in COPD Patients N/A
Recruiting NCT04860375 - Multidisciplinary Management of Severe COPD N/A